RANDOX APOLIPOPROTEIN CALIBRATOR

K023158 · Randox Laboratories, Ltd. · JIX · Oct 24, 2002 · Clinical Chemistry

Device Facts

• Record ID: K023158
• Device Name: RANDOX APOLIPOPROTEIN CALIBRATOR
• Applicant: Randox Laboratories, Ltd.
• Product Code: JIX · Clinical Chemistry
• Decision Date: Oct 24, 2002
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 862.1150
• Device Class: Class 2

Intended Use

The Randox Laboratories Limited Apolipoprotein Calibrator is based on lyophilised human serum and has been developed for use in the calibration of Apolipoprotein A-1 and Apolipoprotein B assays. The constituent concentrations of the Randox Laboratories Limited Apolipoprotein Calibrator are present at 1 level. The Randox Labotatories Limited Apolipoprotein Calibrator should only be used by suitably qualified personnel, under appropriate laboratory conditions.

Device Story

Apolipoprotein Calibrator is a lyophilized human serum-based product; used for calibration of Apolipoprotein A-1 and Apolipoprotein B assays. Device is intended for professional use in clinical laboratory environments. Product provides a standardized reference point at a single concentration level to ensure accuracy of diagnostic assay results. Facilitates clinical decision-making by ensuring reliable quantification of apolipoproteins, which are markers for lipid metabolism and cardiovascular risk assessment.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Lyophilized human serum-based calibrator; single-level concentration; intended for in vitro diagnostic use; no electronic or software components.

Indications for Use

Indicated for use in the calibration of Apolipoprotein A-1 and Apolipoprotein B assays in clinical laboratory settings by qualified personnel.

Regulatory Classification

Identification

A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)

Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

Submission Summary (Full Text)

{0}------------------------------------------------

## DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and wing. The eagle faces to the right. Encircling the eagle is the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement.

Food and Drug Administration 098 Gaither Road Rockville MD 20850

Dr. Pauline Armstrong Randox Laboratories, Ltd. Biochemical Manufacturers Ardmore, Diamond Road Crumlin, CO. Antrim United Kingdom BT29 4QY

OCT 2 4 2002

Re: k023158

Trade/Device Name: APOLIPROTEIN CALIBRATOR Regulation Number: 21 CFR 862.1150 Regulation Name: Calibrator Regulatory Class: Class II Product Code: JIX Dated: September 16, 2002 Received: September 23, 2002

Dear Dr. Armstrong:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

Page 2 -

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and " additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers International and Consumer Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrlvdsma/dsmamain.html".

Sincerely yours,

Steven Sutman

Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory-Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

510(k) Number (if known)

Ko23158 NOT KNOWN

Device Name:

## APOLIPOPROTEIN CALIBRATOR

Indications For Use :

The Randox Laboratories Limited Apolipoprotein Calibrator is based on lyophilised human serum and has been developed for use in the calibration of Apolipoprotein A-1 and Apolipoprotein B assays. The constituent concentrations of the Randox Laboratories Limited Apolipoprotein Calibrator are present at 1 level.

The Randox Labotatories Limited Apolipoprotein Calibrator should only be used by suitably qualified personnel, under appropriate laboratory conditions.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

OR

Over-The-Counter Use (Optional format 1-2-96)

Juan Cooper

(Division Sign-Off) Division of Clinical Labgratory 510(k) Number -